Table of Contents 2
List of Tables 6
List of Figures 6
3SBio Inc. Spshot 7
3SBio Inc. Overview 7
Key Information 7
Key Facts 7
3SBio Inc. - Research and Development Overview 8
Key Therapeutic Areas 8
3SBio Inc. - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Combition Treatment Modalities 13
Pipeline Products - Partnered Products 14
Partnered Products/Combition Treatment Modalities 15
3SBio Inc. - Pipeline Products Glance 16
3SBio Inc. - Late Stage Pipeline Products 16
Phase III Products/Combition Treatment Modalities 16
3SBio Inc. - Clinical Stage Pipeline Products 17
Phase II Products/Combition Treatment Modalities 17
Phase I Products/Combition Treatment Modalities 18
3SBio Inc. - Early Stage Pipeline Products 19
IND/CTA Filed Products/Combition Treatment Modalities 19
Preclinical Products/Combition Treatment Modalities 20
3SBio Inc. - Drug Profiles 21
(clindamycin phosphate + tretinoin) 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AT-101 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
SSS-06 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
SSS-07 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
(tipiracil hydrochloride + trifluridine) 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
cicalcet hydrochloride 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
colestilan chloride 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
eltrombopag olamine 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
droparin calcium 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
PEG-EPO 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
PEG-irinotecan 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
pegadricase 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
sevelamer carbote 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
trelagliptin succite 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
(betamethasone valerate + calcipotriene) 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
APG-1387 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
desonide 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
DJ-5 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
DNP-001 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
ferric citrate 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
fondaparinux sodium 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
PMC-001 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Small Molecule to Inhibit HIF-PH for Rel Anemia 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
SSS-08 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
thrombopoietin 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
TTAC-0001 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
3SBio Inc. - Pipeline Alysis 55
3SBio Inc. - Pipeline Products by Target 55
3SBio Inc. - Pipeline Products by Route of Administration 57
3SBio Inc. - Pipeline Products by Molecule Type 58
3SBio Inc. - Pipeline Products by Mechanism of Action 59
3SBio Inc. - Recent Pipeline Updates 61
3SBio Inc. - Dormant Projects 75
3SBio Inc. - Discontinued Pipeline Products 76
Discontinued Pipeline Product Profiles 76
NuLeusin 76
3SBio Inc. - Company Statement 77
3SBio Inc. - Locations And Subsidiaries 78
Head Office 78
Other Locations & Subsidiaries 78
Appendix 80
Methodology 80
Coverage 80
Secondary Research 80
Primary Research 80
Expert Panel Validation 80
Contact Us 80
Disclaimer 81